High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

There were 26 patients enrolled in a pilot study of high-dose immunosuppressive therapy (HDIT) for severe multiple sclerosis (MS). Median baseline expanded disability status scale (EDSS) was 7.0 (range, 5.0–8.0). HDIT consisted of total body irradiation, cyclophosphamide, and antithymocyte globulin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nash, Richard A., Bowen, James D., McSweeney, Peter A., Pavletic, Steven Z., Maravilla, Kenneth R., Park, Man-soo, Storek, Jan, Sullivan, Keith M., Al-Omaishi, Jinan, Corboy, John R., DiPersio, John, Georges, George E., Gooley, Theodore A., Holmberg, Leona A., LeMaistre, C. Fred, Ryan, Kate, Openshaw, Harry, Sunderhaus, Julie, Storb, Rainer, Zunt, Joseph, Kraft, George H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2003
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963562/
https://ncbi.nlm.nih.gov/pubmed/12763935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2002-12-3908
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge